Atlas Molecular Pharma

Quick facts

Phase 3 pipeline

• Ciclopirox Olamine Oral · Infectious Disease / Dermatology
  Ciclopirox olamine is a broad-spectrum antifungal agent that inhibits fungal cytochrome P450 enzymes and disrupts fungal cell membrane integrity.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Atlas Molecular Pharma portfolio CI brief
• Atlas Molecular Pharma pipeline updates RSS